RxDoctor Payments Data

Erika Rooney

Family · Hendersonville, TNNPI 1467177725

Payments from drug & device makers

$4,317in general payments, 2019–2025

Across 219 payments — averaging $19.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$708
  • Novo Nordisk$551
  • AstraZeneca$525
  • Astellas Pharma US Inc$381
  • Pfizer$273
  • Lilly USA, LLC$234
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$4,317100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,317 in reported general payments places this provider in the 85th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide41$64,416
JardianceEmpagliflozin50$53,649
EliquisApixaban35$43,056
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$32,306
TrulicityDulaglutide18$31,525
FarxigaDapagliflozin Propanediol25$27,948
XareltoRivaroxaban25$27,707
MounjaroTirzepatide16$22,885
MyrbetriqMirabegron27$21,006
JanuviaSitagliptin Phosphate16$18,216
Tresiba Flextouch U-100Insulin Degludec12$6,239
Albuterol Sulfate HfaAlbuterol Sulfate54$3,711
Atorvastatin Calcium300$3,405
SynthroidLevothyroxine Sodium44$3,238
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$3,103

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$551$64,41641 claims
Lilly USA, LLCTrulicity, Mounjaro$234$54,41034 claims
PfizerEliquis$273$43,05635 claims
GSKTrelegy Ellipta$234$32,30625 claims
AstraZenecaFarxiga$525$27,94825 claims
Astellas Pharma US IncMyrbetriq$381$21,00627 claims
AbbVieSynthroid$708$3,23844 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$18$2,701271 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,706 family providers in Tennessee.

Other family in Hendersonville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →